Trial intelligence / Profile preview

IPACK block efficiency as aid for ACB after total knee arthroplasty (pilot study)

DRKS00019069Phase 4Completed

Sponsor
Hospital of Traumatology and Orthopaedics
Start
Nov 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in postoperative pain and Not applicable (2 arms), sponsored by Hospital of Traumatology and Orthopaedics. Started Nov 2019; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative painNot applicable

Beyond the preview

Go deeper on DRKS00019069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00019069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call